Fund shareholders of Hansa Biopharma AB
ISIN SE0002148817 · Sweden · LEI 549300LLEO25ZJJ3NT91
- Fund shareholders
- 25
- Of which ETFs
- 3 22 other funds
- Value held
- ≈ 24.3M $ 144.4M SEK · 9.1M $
- Sold short
- 2.1 % by 3 funds, as of Aug 20, 2026
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 2,290,077 | 8.4M $ | 0.16 % | as of May 31, 2026 ↗ |
| Handelsbanken Norden Index Criteria Handelsbanken Fonder AB | 1,705,165 | 54.4M SEK | 0.16 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Sverige Index Criteria Handelsbanken Fonder AB | 602,323 | 19.2M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 486,404 | 15.5M SEK | 0.49 % | as of Mar 31, 2026 ↗ |
| SEB Sverige Indexnära SEB Funds AB | 476,840 | 15.2M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Plus Storebrand Asset Management AS | 252,865 | 8.1M SEK | 0.04 % | as of Mar 31, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 233,653 | 7.4M SEK | 0.75 % | as of Mar 31, 2026 ↗ |
| SEB Sverige Indexfond SEB Funds AB | 214,603 | 6.8M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF SPDR INDEX SHARES FUNDS | 169,225 | 619K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Skandia Sverige Exponering Skandia Fonder AB | 148,110 | 4.7M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Småbolag Plus Storebrand Asset Management AS | 109,177 | 3.5M SEK | 0.11 % | as of Mar 31, 2026 ↗ |
| Lysa Sweden Equity Broad Lysa Fonder AB | 57,551 | 1.8M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| Skandia Balanserad Skandia Fonder AB | 44,071 | 1.4M SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| Lannebo Marknad Sverige Bred Lannebo Kapitalförvaltning AB | 39,405 | 1.3M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF SPDR INDEX SHARES FUNDS | 36,645 | 134K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| PLUS Småbolag Sverige Index ISEC Services AB | 34,774 | 1.1M SEK | 0.10 % | as of Mar 31, 2026 ↗ |
| Avanza Impact by Circulus Avanza Fonder AB | 33,440 | 1.1M SEK | 1.82 % | as of Mar 31, 2026 ↗ |
| PLUS Allabolag Sverige Index ISEC Services AB | 33,147 | 1.1M SEK | 0.03 % | as of Mar 31, 2026 ↗ |
| Skandia Världen Sverige Skandia Fonder AB | 24,002 | 765.2K SEK | 0.01 % | as of Mar 31, 2026 ↗ |
| PLUS Hälsovård Sverige Index ISEC Services AB | 18,705 | 596.3K SEK | 1.02 % | as of Mar 31, 2026 ↗ |
| Småbolag Sverige Exponering Skandia Fonder AB | 8,941 | 285K SEK | 0.11 % | as of Mar 31, 2026 ↗ |
| Skandia Försiktig Skandia Fonder AB | 3,518 | 112.2K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| Skandia Mix 60 Exponering Skandia Fonder AB | 2,462 | 78.5K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| Skandia Mix 100 Exponering Skandia Fonder AB | 1,457 | 46.4K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio Europe ETF SPDR INDEX SHARES FUNDS | 1,436 | 5.3K $ | 0.00 % | as of Jun 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Avanza Impact by Circulus Avanza Fonder AB | 1.82 % | as of Mar 31, 2026 ↗ |
| PLUS Hälsovård Sverige Index ISEC Services AB | 1.02 % | as of Mar 31, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 0.75 % | as of Mar 31, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 0.49 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Norden Index Criteria Handelsbanken Fonder AB | 0.16 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.16 % | as of May 31, 2026 ↗ |
| Storebrand Sverige Småbolag Plus Storebrand Asset Management AS | 0.11 % | as of Mar 31, 2026 ↗ |
| Småbolag Sverige Exponering Skandia Fonder AB | 0.11 % | as of Mar 31, 2026 ↗ |
| PLUS Småbolag Sverige Index ISEC Services AB | 0.10 % | as of Mar 31, 2026 ↗ |
| Storebrand Sverige Plus Storebrand Asset Management AS | 0.04 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 4 | -1 | 2,497,383 | +79.8 % |
| 2026Q2 | 5 | 0 | 1,389,099 | +0.7 % |
| 2026Q1 | 5 | +2 | 1,378,772 | +627.5 % |
| 2025Q4 | 3 | 0 | 189,515 | +8.5 % |
| 2025Q3 | 3 | 0 | 174,674 | +1.4 % |
| 2025Q2 | 3 | 0 | 172,318 | +8.3 % |
| 2025Q1 | 3 | 0 | 159,070 | +1.7 % |
| 2024Q4 | 3 | 0 | 156,480 | +1.6 % |
| 2024Q3 | 3 | 0 | 154,004 | +2.1 % |
| 2024Q2 | 3 | 0 | 150,836 | +0.9 % |
| 2024Q1 | 3 | 0 | 149,543 | +2.2 % |
| 2023Q4 | 3 | 146,309 |
Short sellers of Hansa Biopharma AB
Regulators publish the open short positions in this company. Titelia read them from quivad on Aug 20, 2026: today's figure
| Seller | Position | Disclosed on |
|---|---|---|
| ActusRayPartners Limited | 0.9 % | Aug 7, 2026 |
| Connor Clark & Lunn Investment Management Ltd. | 0.6 % | Aug 11, 2026 |
| GSA Capital Partners LLP | 0.6 % | Aug 14, 2026 |
Cite this page
Titelia. "Fund shareholders of Hansa Biopharma AB". https://titelia.com/en/stocks/hansa-biopharma-ab-SE0002148817